Citius Oncology (CTOR) Operating Expenses (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Operating Expenses of $30.0 million for Q1 2026, up 300.89% year-over-year from $7.5 million in Q1 2025, and up 256.27% quarter-over-quarter from $8.4 million in Q4 2025.
Citius Oncology (CTOR) Operating Expenses (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Operating Expenses for 4 consecutive years, with $30.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 300.89% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $48.0 million (up 72.9% YoY), while the FY2025 annual figure was $23.5 million, up 14.34% from the prior year.
- Operating Expenses grew to $30.0 million in Q1 2026 per CTOR's latest filing, from $8.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $30.0 million in Q1 2026 and bottomed at $177922.0 in Q1 2023.
- Historically, Operating Expenses has averaged $7.6 million across 4 years, with a median of $5.7 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses jumped 5956.88% — and 2025, when it sank 64.43%.
- Citius Oncology's Operating Expenses stood at $4.6 million in 2023, then surged by 39.52% to $6.4 million in 2024, then soared by 31.47% to $8.4 million in 2025, then jumped by 256.27% to $30.0 million in 2026.
- Business Quant data shows CTOR's Operating Expenses at $30.0 million in Q1 2026, $8.4 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Citius Oncology | 80.17 Mn | 80.17 Mn | 1.00 Mn | 9.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.95 Mn |
| Dec 31, 2025 | 8.41 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2025 | 7.47 Mn |
| Dec 31, 2024 | 6.39 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Mar 31, 2024 | 9.27 Mn |
| Dec 31, 2023 | 4.58 Mn |
| Sep 30, 2023 | 858,931.00 |
| Jun 30, 2023 | 229,554.00 |
| Mar 31, 2023 | 177,922.00 |